Market Cap 468.57B
Revenue (ttm) 61.16B
Net Income (ttm) 4.23B
EPS (ttm) N/A
PE Ratio 24.33
Forward PE 18.82
Profit Margin 6.91%
Debt to Equity Ratio -12.03
Volume 3,469,200
Avg Vol 4,846,830
Day's Range N/A - N/A
Shares Out 1.77B
Stochastic %K 72%
Beta 0.29
Analysts Strong Sell
Price Target $277.87

Company Profile

AbbVie Inc., a research-based biopharmaceutical company, engages in the research and development, manufacturing, commercializing, and sale of medicines and therapies worldwide. The company offers Skyrizi to treat autoimmune diseases; Rinvoq to treat inflammatory diseases; Imbruvica for the treatment of adult patients with blood cancers; Venclexta to treat blood cancers; Elahere to treat various cancer; and Epkinly to treat lymphoma; and Emrelis for the treatment of lung cancer. It also provides...

Industry: Drug Manufacturers - General
Sector: Healthcare
Phone: 847 932 7900
Address:
1 North Waukegan Road, North Chicago, United States
Latest News on ABBV
No data available.